BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 6322371)

  • 1. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein receptors.
    Lestavel S; Fruchart JC
    Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):461-81. PubMed ID: 8061563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor interactions controlling lipoprotein metabolism.
    Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
    Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
    Mahley RW; Hui DY; Innerarity TL; Beisiegel U
    Arteriosclerosis; 1989; 9(1 Suppl):I14-8. PubMed ID: 2536272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
    Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
    J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of apolipoproteins in lipid metabolism].
    Karádi I; Kostner GM
    Ther Umsch; 1990 Jun; 47(6):467-74. PubMed ID: 2165281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of macrophages in lipid metabolism.
    Kottke BA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S7-10. PubMed ID: 2447441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principles of cholesterol and bile acid metabolism in the liver and small intestine (I)].
    Stange EF
    Leber Magen Darm; 1986 Jul; 16(4):210-29. PubMed ID: 3018402
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of triglyceride-rich lipoproteins with receptors: modulation by thrombin.
    Gianturco SH; Bradley WA
    Semin Thromb Hemost; 1986 Oct; 12(4):277-9. PubMed ID: 3787267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the high density lipoprotein-receptor cycle in macrophage-cholesterol metabolism.
    Schmitz G; Robenek H; Assmann G
    Klin Wochenschr; 1986 Oct; 64(19):979-85. PubMed ID: 3023738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of apo E-containing lipoproteins with the LDL-receptor-related protein, LRP.
    Harrach-Ruprecht B; Küchenhoff A; Robenek H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():122-3. PubMed ID: 8767486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent pathophysiologic aspects of atherogenesis].
    Kostner G
    Wien Med Wochenschr; 1990 Feb; 140(4):101-9. PubMed ID: 2158191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
    Couderc R; Bailleul S
    Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W; Chen J; Redinger RN
    J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.